Plain-English translation of NCT07480902 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research compares two different methods for detecting early signs of cervical cancer and precancerous changes in the cervix. One method uses a traditional Pap smear (liquid-based cytology), while the other uses molecular screening to look for specific biological markers. The study will help doctors understand which approach is better at catching these changes early, when treatment is most effective.
Cervical cancer is preventable when caught early, but doctors need the most accurate screening tools available. This trial exists to determine whether molecular screening might be more effective than the traditional Pap smear at finding precancerous changes before they develop into cancer.
You likely qualify if…
You likely don't qualify if…
You will attend two study visits. At your first visit, you'll answer health questions, have a physical exam, provide a blood sample, and undergo a colposcopy (a gentle examination of your cervix using a special viewing instrument). If the doctor sees any abnormal areas, a small tissue sample may be taken. At your second visit, about a week or two later, the doctor will explain your test results and provide recommendations. The entire process takes a few hours total.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Mexico